Carregant...
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes
Autoimmune diabetes mellitus is a rare but significant side effect of treatment with immune checkpoint inhibitors. Immune checkpoint inhibitor‐induced diabetes mellitus (CPI‐DM) is characterized by acute onset of dramatic hyperglycemia with severe insulin deficiency and occurrence following exposure...
Guardat en:
| Publicat a: | Clin Exp Immunol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160652/ https://ncbi.nlm.nih.gov/pubmed/32027018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13424 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|